Application of Physiologically-based Pharmacokinetic (PBPK) Modeling for Prediction of the Exposure of Buprenorphine in Neonates: Incorporation of CYP3A4 and UGT1A1 Ontogenies March 3, 2015 By webdev
Application of PBPK and Bayesian Modeling for Prediction of the Likelihood of Individual Patients Experiencing Serious Adverse Reactions to a Standard Dose of Efavirenz March 3, 2015 By webdev
Integrated Pharmacogenomic Analysis Reveals OATP1B1 T521C Polymorphism (rs4149056) Does Not Affect the Pharmacokinetics of Edoxaban March 3, 2015 By webdev
Simulating Cardiac Consequences of the Genetic Variability at the Metabolism Level with Use of Middle-out Approach and Flecainide as an Example Compound March 3, 2015 By webdev
A Model Relating Overall Survival Related to Tumor Growth Inhibition in Renal Cell Carcinoma Patients Treated with Sunitinib, Axitinib or Temsirolimus March 3, 2015 By webdev